---
figid: PMC4516161__nihms702733f4
figlink: /pmc/articles/PMC4516161/figure/F4/
number: Fig. 4
caption: Proposed mechanism of CIB1 regulation of TNBC cell survival and potential
  role of CIB1 in non-oncogene addiction. a CIB1 promotes TNBC cell survival, proliferation,
  and tumor growth via AKT and ERK signaling pathways. b CIB1 depletion results in
  loss of AKT and ERK. This effect is mediated in part by PAK1, but also likely involves
  additional, undetermined factors (dotted line). CIB1 depletion is most effective
  in PTEN-deficient cells and/or cells with elevated AKT activation. Because PTEN
  also acts as an upstream regulator of PI3K/AKT signaling, inactivating mutations
  or deletions of PTEN commonly result in hyper-activation of this pathway. Thus,
  TNBC cells with low or absent PTEN show increased sensitivity to CIB1 depletion.
  Together with the observations that CIB1 depletion/loss has minimal effect on non-cancerous
  cells [] or TNBC cells with wild-type PTEN, our findings suggest a role for CIB1
  in the concept of non-oncogene addiction
pmcid: PMC4516161
papertitle: CIB1 depletion impairs cell survival and tumor growth in triple-negative
  breast cancer.
reftext: Justin L. Black, et al. Breast Cancer Res Treat. ;152(2):337-346.
pmc_ranked_result_index: '60569'
pathway_score: 0.9575747
filename: nihms702733f4.jpg
figtitle: CIB1 regulation of TNBC cell survival and potential role of CIB1 in non-oncogene
  addiction
year: ''
organisms:
- Homo sapiens
ndex: ''
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC4516161__nihms702733f4.html
  '@type': Dataset
  description: Proposed mechanism of CIB1 regulation of TNBC cell survival and potential
    role of CIB1 in non-oncogene addiction. a CIB1 promotes TNBC cell survival, proliferation,
    and tumor growth via AKT and ERK signaling pathways. b CIB1 depletion results
    in loss of AKT and ERK. This effect is mediated in part by PAK1, but also likely
    involves additional, undetermined factors (dotted line). CIB1 depletion is most
    effective in PTEN-deficient cells and/or cells with elevated AKT activation. Because
    PTEN also acts as an upstream regulator of PI3K/AKT signaling, inactivating mutations
    or deletions of PTEN commonly result in hyper-activation of this pathway. Thus,
    TNBC cells with low or absent PTEN show increased sensitivity to CIB1 depletion.
    Together with the observations that CIB1 depletion/loss has minimal effect on
    non-cancerous cells [] or TNBC cells with wild-type PTEN, our findings suggest
    a role for CIB1 in the concept of non-oncogene addiction
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - PIK3CB
  - PIK3CA
  - PIK3R4
  - AKT1
  - NRAS
  - PIK3CD
  - AKT3
  - RAF1
  - AKT2
  - PTEN
  - ARAF
  - PIK3R6
  - KRAS
  - PIK3CG
  - PIK3R5
  - MAPK1
  - MAPK3
  - BRAF
  - CIB1
  - MAP2K1
  - HRAS
  - PAK1
  - PIK3R3
  - MAP2K2
  - Cancer
  - Cardiomyopathy
  - Lung cancer
  - Noonan syndrome
genes:
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CB
  entrez: '5291'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CA
  entrez: '5290'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R4
  entrez: '30849'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: NRAS
  entrez: '4893'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CD
  entrez: '5293'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: RAF
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: RAF1
  entrez: '5894'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: PTEN
  symbol: PTEN
  source: hgnc_symbol
  hgnc_symbol: PTEN
  entrez: '5728'
- word: RAF
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: ARAF
  entrez: '369'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R6
  entrez: '146850'
- word: RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: KRAS
  entrez: '3845'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CG
  entrez: '5294'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R5
  entrez: '23533'
- word: ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: RAF
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: BRAF
  entrez: '673'
- word: CIB1
  symbol: CIB1
  source: hgnc_symbol
  hgnc_symbol: CIB1
  entrez: '10519'
- word: MEK
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K1
  entrez: '5604'
- word: RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: HRAS
  entrez: '3265'
- word: PAK1
  symbol: PAK1
  source: hgnc_symbol
  hgnc_symbol: PAK1
  entrez: '5058'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R3
  entrez: '8503'
- word: MEK
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K2
  entrez: '5605'
chemicals: []
diseases:
- word: Cancer
  source: ''
  identifier: ''
- word: Cardiomyopathy
  source: ''
  identifier: ''
- word: Lung cancer
  source: ''
  identifier: ''
- word: Noonan syndrome
  source: ''
  identifier: ''
---
